• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

Hangover Pill Shows Promise in Lab Tests

By
Chris Morris
Chris Morris
Former Contributing Writer
Down Arrow Button Icon
By
Chris Morris
Chris Morris
Former Contributing Writer
Down Arrow Button Icon
May 11, 2018, 10:59 AM ET

The worst part of a night on the town is often the morning after. But new research is offering hope for people whose evening of excess results in the mother of all hangovers.

Yunfeng Lu, a chemical engineering professor at UCLA (and self-confessed wine enthusiast), has been working on a solution to the negative effects of alcohol. And he says tests in lab mice are showing very promising results.

The pill Lu has overseen is filled with natural enzymes usually found in liver cells that help the body process booze faster. That not only would impact the skull splitting headaches and cotton mouth of a hangover, but could work as a treatment for cases of alcohol poisoning in emergency rooms across the country.

To test the drug, Lu and his associates first had to get a lot of mice drunk. Then, they were given the treatment. The result? A 45% decrease in blood alcohol levels in just four hours compared to mice who weren’t treated.

Mice, of course, rarely complain about hangovers, but Lu found that the levels of acetaldehyde, “a highly toxic compound that is carcinogenic, causes headaches and vomiting, makes people blush after drinking, and is produced during the normal alcohol metabolism, remained extremely low.”

Hangover prevention is a big business for some companies. There are drinks, suits, and even “hangover-free booze” in some areas. The results of all of these, though, have been debatable. Lu’s study is aimed to help hospitals, rather than weekend warriors, though, which earns it special merit.

Don’t go on a bender just yet. Lu and his team are checking to make sure there are no dangerous side effects from the treatment. If that goes well, he says, human tests should begin in a year or so.

And seeing as he’s a professor at a university, he probably won’t have a lot of trouble finding testing candidates.

About the Author
By Chris MorrisFormer Contributing Writer

Chris Morris is a former contributing writer at Coins2Day, covering everything from general business news to the video game and theme park industries.

See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.